Inger Jansen-Olesen Selected Research

Glucose (Dextrose)

6/2007

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inger Jansen-Olesen Research Topics

Disease

39	Migraine Disorders (Migraine) 02/2023 - 12/2005
22	Headache (Headaches) 01/2023 - 09/2008
7	Pain (Aches) 01/2022 - 11/2010
4	Hypersensitivity (Allergy) 01/2022 - 01/2018
2	Stroke (Strokes) 01/2021 - 12/2008
2	Flushing 01/2019 - 02/2018
2	Photophobia (Light Sensitivity) 01/2018 - 07/2016
1	Constipation 05/2022
1	Epilepsy (Aura) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2017
1	Inflammation (Inflammations) 12/2015
1	Hypotension (Low Blood Pressure) 03/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2007

Drug/Important Bio-Agent (IBA)

8	Adenosine Triphosphate (ATP)IBA 02/2023 - 06/2007
8	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 01/2012
7	KATP ChannelsIBA 02/2023 - 08/2017
7	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2023 - 01/2011
6	Calcitonin Gene-Related PeptideIBA 01/2023 - 01/2014
6	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2023 - 01/2011
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 12/2005
5	Cromakalim (Levcromakalim)IBA 01/2023 - 01/2020
5	Peptides (Polypeptides)IBA 01/2023 - 06/2007
5	Vasodilator Agents (Vasodilators)IBA 01/2022 - 09/2008
5	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2018 - 07/2007
5	Sumatriptan (Imigran)FDA LinkGeneric 01/2018 - 01/2012
4	PotassiumIBA 02/2023 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2022 - 11/2010
3	Monoclonal AntibodiesIBA 01/2023 - 01/2022
3	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 02/2018 - 01/2011
3	olcegepantIBA 01/2018 - 02/2014
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 05/2022 - 01/2014
2	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2018
2	AnkyrinsIBA 10/2020 - 08/2019
2	Dinoprostone (PGE2)FDA Link 02/2017 - 09/2010
2	ProstaglandinsIBA 02/2017 - 09/2010
2	Tryptamines (Triptans)IBA 01/2017 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2016 - 07/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2010 - 12/2005
1	NeuropeptidesIBA 01/2023
1	AntibodiesIBA 05/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	KynurenineIBA 01/2021
1	TRPA1 Cation ChannelIBA 10/2020
1	gliquidoneIBA 01/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	Epoprostenol ReceptorsIBA 02/2017
1	Prostaglandin D2IBA 02/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Pregabalin (Lyrica)FDA Link 01/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2017
1	Neurokinin-1 Receptor AntagonistsIBA 12/2015
1	Prednisolone (Predate)FDA LinkGeneric 12/2015
1	3- ((3,5- bis(trifluoromethyl)phenyl)methyloxy)- 2- phenylpiperidineIBA 12/2015
1	Natriuretic PeptidesIBA 12/2015
1	arginine methyl esterIBA 12/2015
1	Serotonin (5 Hydroxytryptamine)IBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 11/2010
1	EnzymesIBA 11/2010
1	Prostaglandins EIBA 09/2010
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 12/2008
1	Glucose (Dextrose)FDA LinkGeneric 06/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2007
1	Insulin (Novolin)FDA Link 06/2007

Therapy/Procedure

5	Therapeutics 01/2023 - 06/2007
1	Injections 01/2020
1	Aftercare (After-Treatment) 07/2016
1	Intravenous Infusions 12/2015
1	Anesthesia 03/2015